Print(PDF/128KB) Sep. 03, 2018 Corporate
Sumitomo Dainippon Pharma announces personnel changes
Sumitomo Dainippon Pharma Co., Ltd. (Head Office: Osaka, Japan; Representative Director, President and CEO: Hiroshi Nomura) today announced the following personal changes:
Changes in Personnel (effective October 1, 2018)
Corporate Regulatory Compliance & Quality Assurance (Division)
Position as of October 1, 2018 | Current position | Name |
---|---|---|
Senior Director, Regulatory Compliance & Quality Assurance Management | Senior Director, Ehime Plant | Hiroshi Noda |
Drug Research (Division)
Position as of October 1, 2018 | Current position | Name |
---|---|---|
Senior Director, Preclinical Research Unit Director, Toxicology Group I, Preclinical Research Unit |
Director, Toxicology Group I, Preclinical Research Unit | Izuru Miyawaki |
Manufacturing (Division)
Position as of October 1, 2018 | Current position | Name |
---|---|---|
Senior Director, Ibaraki Plant Senior Director, Ehime Plant |
Senior Director, Ibaraki Plant | Hiroyuki Nishii |
Inquiries from the Press